| ID | Sequence | Length | GC content |
|---|---|---|---|
| GCAGCUCGGAGCGCUAGAGAGACGCGGCGGCGCUGGCAGAAGAGGCGGC… | 4013 nt | 0.4451 | |
| GCAGCUCGGAGCGCUAGAGAGACGCGGCGGCGCUGGCAGAAGAGGCGGC… | 4130 nt | 0.4610 | |
| GCAGCUCGGAGCGCUAGAGAGACGCGGCGGCGCUGGCAGAAGAGGCGGC… | 3711 nt | 0.4441 | |
| GCAGCUCGGAGCGCUAGAGAGACGCGGCGGCGCUGGCAGAAGAGGCGGC… | 3470 nt | 0.4239 | |
| GCAGCUCGGAGCGCUAGAGAGACGCGGCGGCGCUGGCAGAAGAGGCGGC… | 3409 nt | 0.4233 | |
| AGUGCGUGCCGGGUGCGGCGCCAGCAGCGGAGGGGCGGCCCGGCGCCCA… | 4437 nt | 0.4618 |
Predicted to enable several functions, including clathrin adaptor activity; clathrin heavy chain binding activity; and phosphatidylinositol binding activity. Acts upstream of or within regulation of clathrin-dependent endocytosis. Predicted to be located in cytosol; postsynaptic density; and presynaptic membrane. Predicted to be active in several cellular components, including Schaffer collateral - CA1 synapse; cytoplasmic vesicle; and parallel fiber to Purkinje cell synapse. Predicted to be extrinsic component of presynaptic endocytic zone membrane. Biomarker of Alzheimer's disease. [provided by Alliance of Genome Resources, Apr 2025]
A study in mice demonstrated that the SNAP91 was identified as a hub gene related to synaptic plasticity during the addicting phase of nicotine self-administration in the ventral tegmental area [Fan et al. DOI:10.1016/J.Jgg.2024.08.009].